People news

Share this article:
Agile Therapeutics, a specialty pharmaceutical company focused on women's healthcare products, has appointed Al Altomari as chairman of its board of directors. Altomari currently serves as CEO of Barrier Therapeutics. Prior to Barrier, Altomari held several executive roles at Johnson & Johnson, and worked for Ortho-McNeil Pharmaceutical's women's health care franchise.

Introgen Therapeutics, a developer of molecular therapies for cancer, has appointed James Rothman, PhD, to the company's board of directors. Rothman previously served as vice chairman of the Sloan-Kettering Research Institute of Memorial Sloan-Kettering cancer Center.
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Channel

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.